BioPharma Credit (OTCMKTS:BOPCF) Trading 13% Higher – Here’s Why

BioPharma Credit PLC (OTCMKTS:BOPCFGet Free Report) shot up 13% during mid-day trading on Tuesday . The company traded as high as $0.94 and last traded at $0.94. 140 shares were traded during trading, a decline of 100% from the average session volume of 67,608 shares. The stock had previously closed at $0.83.

BioPharma Credit Stock Performance

The stock has a fifty day simple moving average of $0.84 and a 200-day simple moving average of $0.83.

BioPharma Credit Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 7th. Shareholders of record on Friday, April 4th were issued a dividend of $0.0175 per share. The ex-dividend date of this dividend was Friday, April 4th. This is a boost from BioPharma Credit’s previous quarterly dividend of $0.01. This represents a $0.07 dividend on an annualized basis and a dividend yield of 7.47%.

About BioPharma Credit

(Get Free Report)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.

Read More

Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.